| Today, the U.S. Food and Drug Administration (FDA) updated the Technical Considerations for Non-Clinical Assessment of Medical Devices Containing Nitinol final guidance to clarify acceptance criteria for nitinol transformation temperatures when evaluating nitinol psuedoelastic properties. The final guidance was previously issued on October 15, 2020. The guidance outlines technical recommendations about information industry should include in premarket submissions for medical devices containing nitinol. Questions? If you have questions about this final guidance, contact the Division of Industry and Consumer Education. | | | |
No comments:
Post a Comment